# 1. Financial Performance ## A. Key Figures * Revenue from Operations: ₹528.29 Cr Q1 FY25-26 (+7%) · ₹493.58 Cr Q1 FY24-25 * EBITDA: ₹83.19 Cr Q1 FY25-26 · ₹71.72 Cr Q1 FY24-25 * **PAT:** **₹55.5 Cr** Q1 FY25-26 · **₹48.89 Cr** Q1 FY24-25 ## B. Revenue Growth * **Modest Top-Line Expansion:** 7% revenue growth driven by **5% volume increase** and a **one-time ₹9 Cr payment** from Bayer India for net economic benefit. * **Royalty Contribution:** **₹13 Cr royalty income** fully attributed to the two Bayer-acquired products, establishing a new, high-margin revenue stream. * **Pricing Tailwinds:** Technical prices stabilizing and trending upward, supporting an expected **2% value improvement** for the year despite flat volumes. ## C. Profitability Trends * **Sharp Earnings Contraction:** Significant decline in EBITDA and PAT year-on-year, reflecting base effects and loss of prior cost advantages. ## D. Margin Pressures * **Margin Headwinds Emerge:** Gross margin pressure from **ban on a high-margin biofertilizer molecule** and absence of prior-year tailwinds from falling input prices. * **Erosion Forecast:** Despite a **year-on-year EBITDA margin increase in Q1**, full-year outlook points to **~100 bps contraction** due to lower-margin product mix and stabilized input costs. ## E. Cash Flow & Buyback * **Shareholder Return Executed:** Completed buyback of **5 lakh equity shares**, signaling capital discipline and confidence in long-term value. --- # 2. Product & Segment Performance ## A. Key Figures * **Product Mix:** **50%** herbicides · **23%** insecticides · **11%** fungicides · **16%** others * **High-Value Brands:** **~10 brands** generating >₹50 Cr annually * **Royalty Income:** **₹9 Cr** from Bayer products (Q1) * **Others Segment Growth:** **Double-digit growth** in technical-grade molecules, bulk products, and PGRs ## B. Herbicide Performance * **Market Leadership with Competitive Pressure:** Targa Super maintains strong farmer preference in soybean and cotton despite rising generic competition, with expanding use in onion and black gram. * **Regional Demand Volatility:** Performance impacted by **muted herbicide consumption in key soybean markets** (Madhya Pradesh), affecting Dhanuka’s growth. * **Strategic Crop Expansion:** Core focus on rice, sugarcane, maize, and horticulture crops like grapes, with joint field teams (Hokko-Dhanuka) driving Dinkar adoption in South Indian paddy markets. ## C. Insecticide & Fungicide Demand * **Favorable Seasonal Tailwinds:** Fungicide demand surged due to widespread and intense rainfall, while insecticide uptake is expected to rise in line with seasonal patterns. ## D. Branded Product Portfolio * **Portfolio Scalability:** Significant expansion in high-performing brands (>₹50 Cr revenue) over five years, with **roughly half developed through partnerships** and half in-house. ## E. Traded & Bulk Revenue * **Niche Traded Portfolio:** Traded segment includes **7–8 branded products** (e.g., TORNADO, Dabooch) sourced via tie-ups, sold in packed form. * **Limited B2B Contribution:** B2B sales were not material in Q1, with no disclosed EBITDA contribution. --- # 3. Geography & Channel Mix ## A. Key Figures * **Sales Mix:** **31%** North India · **9%** East India · **41%** West India · **19%** South India ## B. Regional Sales Distribution * **Challenging YoY Comparison:** Soft Q1 performance driven by Dhanuka’s exceptionally strong prior-year base, which was significantly ahead of peers, creating a high benchmark. ## C. Channel Inventory Levels * **Herbicide Inventory Glut:** Elevated stock levels concentrated in herbicide segment across key cotton and soybean states—Madhya Pradesh, Maharashtra, Karnataka, and Telangana—due to weak consumption. --- # 4. Manufacturing & Capacity ## A. Key Figures * **Dahej Revenue (FY26E):** **₹65 Cr** (annual projection) * Dahej Q1 EBITDA: -₹3 Cr (loss) · Revenue: ₹16.5 Cr ## B. Dahej Plant Output * **Progressive Ramp-Up:** Dahej plant on track to meet annual revenue targets, with second product launch expected in H2 FY26, signaling phased operational scaling. * **Export Pipeline Narrow but Strategic:** Only bifenthrin under international registration; exports currently limited to Dahej-manufactured products and Melody range. * **Growth Catalysts:** Dahej plant establishment and **acquisition of 2 Bayer brands** mark strategic expansion into **20+ countries**, fueling next-phase global reach. ## C. Capacity Utilization * **Moderate Utilization:** Group-wide capacity utilization expected at **~60%** for the year, reflecting ongoing ramp-up and market absorption phase. ## D. New Product Launches * **Targeted Innovation:** Successful launch of **Dinkar herbicide** (paddy) via Hokko collaboration, gaining traction in South India. * **Portfolio Recalibration:** Strategy reset in soybean and cotton herbicides; recent launches include **LaNevo (insecticide)**, **MYCORe Super (plant nutrition)**, and **Purge (soybean herbicide)** to address gaps. --- # 5. R&D & Partnerships ## A. Molecule Development * **Focus on Innovation:** Emphasis on novel chemistries and robust product development via two R&D labs, NABL-accredited facilities, and a dedicated registration team. * **Launch Cycle Impact:** Q1 ITI index decline attributed to fewer new molecule launches this year versus high-weight legacy products from three years ago. * **Pipeline Momentum:** Multiple generic products in advanced stages of development, with further announcements expected ahead of next fiscal. ## B. Global Collaborations * **Strategic Alliances:** Partnerships with **10 leading agrochemical firms** from the U.S., Japan, and Europe to bring cutting-edge technologies to Indian agriculture. * **Farmer-Centric Outreach:** Collaborations with agriculture universities, Krishi Vigyan Kendra, and institutions to promote technology adoption and support food security. * **Commercial Launch:** New paddy herbicide **Dinkar**, co-developed with **Hokko Japan**, now being distributed and consumed in **Telangana and Andhra Pradesh**. * **CDMO Prospects:** Active discussions on formulation-side CDMO contracts; however, **no agreements finalized** to date. ## C. Registration Pipeline * **Global Registration Progress:** Melody range and triadimenol registered in **over 25 countries**, with filings planned in **6 to 7 new markets** this year. * **Second Product Rollout:** A second product set for launch in H2, supporting international portfolio expansion. --- # 6. Risks & Monsoon Impact ## A. Key Figures * **Q1 FY'26 Revenue Growth:** **7%** (YoY) ## B. Rainfall Disruptions * **Monsoon-Driven Demand Volatility:** Q1 agrochemical demand weakened due to delayed and uneven monsoon rains, disrupting Kharif sowing—particularly for soybean and cotton—and causing resowing that missed critical herbicide application windows. * **Demand Deferral, Not Destruction:** Despite initial setbacks, management views herbicide demand as largely deferred rather than lost, supported by recent heavy rainfall improving soil moisture and crop prospects. * **Improved Outlook with Seasonal Recovery:** Favorable rainfall in Central India during August–September has boosted field conditions, lifting near-term demand and supporting stable to upward pricing trends. ## C. Farmer Purchase Caution * **Channel Dynamics Weigh on Sales:** Farmer purchasing caution persisted due to rainfall uncertainty and lower prior-harvest realizations, compounded by elevated channel inventories in select regions. ## D. Chinese Price Pressure * **Global Demand Recovery Offsets Oversupply:** Chinese export pressure continues, but improving demand in the U.S., Latin America, and Europe is helping absorb excess supply, despite lingering inventories of certain products. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Growth (Q1):** **7%** YoY (+33% prior year) * **EBITDA Margin Guidance:** **~100 bps decline** expected for FY ## B. Full-Year Revenue View * **Guidance Maintained:** Management reaffirms **double-digit revenue growth** outlook for FY, despite soft Q1, citing improved monsoon trends and rising agrochemical demand. * **Upside Potential:** Confidence in achieving **higher-end double-digit growth** underpinned by favorable weather and stronger consumption of herbicides, insecticides, and fungicides. ## C. Margin Forecast * **Margin Pressure Ahead:** EBITDA margin expected to contract by ~100 bps, with full impact anticipated in coming quarters due to lower-end growth trajectory and operational dynamics. ## D. Seasonal Recovery Expectations * **Seasonal Rebound Building:** Late June 2025 rainfall improvements support optimism for **Q2 FY'26 recovery**, with India on track for **record Kharif food grain production** amid above-normal monsoon forecasts. * **Mixed Demand Signals:** July agrochemical consumption improved sequentially, though **soybean weedicide demand remained weak** and inventory drawdowns from market stock retrieval muted net volume growth.